Correlation Between Regenicin and Denali Therapeutics
Can any of the company-specific risk be diversified away by investing in both Regenicin and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regenicin and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regenicin and Denali Therapeutics, you can compare the effects of market volatilities on Regenicin and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regenicin with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regenicin and Denali Therapeutics.
Diversification Opportunities for Regenicin and Denali Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Regenicin and Denali is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Regenicin and Denali Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Regenicin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regenicin are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Regenicin i.e., Regenicin and Denali Therapeutics go up and down completely randomly.
Pair Corralation between Regenicin and Denali Therapeutics
If you would invest 2,512 in Denali Therapeutics on September 2, 2024 and sell it today you would lose (12.00) from holding Denali Therapeutics or give up 0.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Regenicin vs. Denali Therapeutics
Performance |
| Timeline |
| Regenicin |
| Denali Therapeutics |
Regenicin and Denali Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Regenicin and Denali Therapeutics
The main advantage of trading using opposite Regenicin and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regenicin position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.| Regenicin vs. Denali Therapeutics | Regenicin vs. Cardiff Oncology | Regenicin vs. Cytodyn | Regenicin vs. Inovio Pharmaceuticals |
| Denali Therapeutics vs. Tff Pharmaceuticals | Denali Therapeutics vs. Eliem Therapeutics | Denali Therapeutics vs. Inhibrx | Denali Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |